Carbamazepine intervention in a patient with efavirenz-induced liver injury

AIDS. 2019 May 1;33(6):1097-1098. doi: 10.1097/QAD.0000000000002116.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Alanine Transaminase / blood
  • Alkynes
  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / adverse effects*
  • Aspartate Aminotransferases / blood
  • Benzoxazines / administration & dosage
  • Benzoxazines / adverse effects*
  • Bilirubin / blood
  • Carbamazepine / administration & dosage*
  • Chemical and Drug Induced Liver Injury / drug therapy*
  • Cyclopropanes
  • Cytochrome P-450 CYP2B6 Inducers / administration & dosage*
  • Cytochrome P-450 CYP3A Inducers / administration & dosage*
  • Humans
  • Male
  • Middle Aged
  • Treatment Outcome

Substances

  • Alkynes
  • Anti-HIV Agents
  • Benzoxazines
  • Cyclopropanes
  • Cytochrome P-450 CYP2B6 Inducers
  • Cytochrome P-450 CYP3A Inducers
  • Carbamazepine
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • efavirenz
  • Bilirubin